Aarey Drugs & Pharmaceuticals Limited — Others, 27-12-2024: Corrigendum

Aarey Drugs & Pharmaceuticals has issued a corrigendum for the notice of its upcoming Extraordinary General Meeting, scheduled for January 2, 2025. Key updates include the correct PAN for an allottee, details on the intended use of funds for factory expansion, and the shareholding pattern before and after the preferential issue. Post-issue, promoter shareholding will increase to 49.78%, while public holding will drop to 50.22%. This update clarifies previous inconsistencies and may enhance transparency, potentially fostering a positive outlook among investors who appreciate clearer governance and strategic growth intentions.